Therapeutic Area | MeSH |
---|---|
nervous system diseases | D009422 |
mental disorders | D001523 |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ADDERALL XR 10 | Takeda | N-021303 RX | 2001-10-11 | 1 products, RLD |
ADDERALL XR 20 | Takeda | N-021303 RX | 2001-10-11 | 1 products, RLD |
ADDERALL XR 30 | Takeda | N-021303 RX | 2001-10-11 | 1 products, RLD, RS |
ADDERALL XR 25 | Takeda | N-021303 RX | 2002-05-22 | 1 products, RLD |
ADDERALL XR 5 | Takeda | N-021303 RX | 2002-05-22 | 1 products, RLD |
ADDERALL XR 15 | Takeda | N-021303 RX | 2002-05-22 | 1 products, RLD |
MYDAYIS | Takeda | N-022063 RX | 2017-06-20 | 4 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
DYANAVEL XR | Tris Pharma | N-208147 RX | 2015-10-19 | 1 products, RLD, RS |
DYANAVEL XR 5 | Tris Pharma | N-210526 RX | 2021-11-04 | 1 products, RLD |
DYANAVEL XR 10 | Tris Pharma | N-210526 RX | 2021-11-04 | 1 products, RLD |
DYANAVEL XR 15 | Tris Pharma | N-210526 RX | 2021-11-04 | 1 products, RLD |
DYANAVEL XR 20 | Tris Pharma | N-210526 RX | 2021-11-04 | 1 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ADZENYS XR-ODT | Neos Therapeutics | N-204326 RX | 2016-01-27 | 6 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
adderall | New Drug Application | 2025-03-13 |
adderall xr | New Drug Application | 2010-03-29 |
adzenys xr-odt | New Drug Application | 2024-11-07 |
amphetamine sulfate | ANDA | 2025-02-10 |
dextroamphetamine saccharate and amphetamine aspartate and dextroamphetamine sulfate and amphetamine sulfate | ANDA | 2023-10-20 |
dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate | ANDA | 2025-03-17 |
dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate | ANDA | 2024-02-05 |
dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate extended-release | ANDA | 2024-02-01 |
dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate | ANDA | 2024-12-27 |
dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate extended-release | ANDA | 2024-01-12 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
narcolepsy | EFO_0000614 | D009290 | G47.4 |
attention deficit disorder with hyperactivity | EFO_0003888 | D001289 | F90 |
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Amphetamine / Amphetamine Aspartate/Dextroamphetamine Sulfate, Dyanavel Xr 10, Tris Pharma Inc | |||
11590081 | 2038-09-24 | DP | U-3538 |
8337890 | 2027-03-15 | DP | |
9675704 | 2027-03-15 | DP | |
Amphetamine Sulfate, Evekeo Odt, Azurity | |||
10441554 | 2037-03-10 | DP | |
11160772 | 2037-03-10 | DP | |
11896562 | 2037-03-10 | U-3299 | |
10130580 | 2024-04-19 | DP | |
Amphetamine / Amphetamine Aspartate/Dextroamphetamine Sulfate, Dyanavel Xr, Tris Pharma Inc | |||
11590228 | 2036-09-07 | DP | U-3538 |
8062667 | 2029-03-29 | DP | |
8597684 | 2027-03-15 | DP | |
8747902 | 2027-03-15 | DP | |
8883217 | 2027-03-15 | DP | |
9675703 | 2027-03-15 | DP | |
10086087 | 2027-03-15 | DP | |
Amphetamine, Adzenys Er, Neos Theraps Inc | |||
8709491 | 2032-06-28 | DP | |
9017731 | 2032-06-28 | DP | |
9265737 | 2032-06-28 | DP | |
Amphetamine Aspartate / Amphetamine Sulfate / Dextroamphetamine Saccharate / Dextroamphetamine Sulfate, Mydayis, Takeda Pharms Usa | |||
8846100 | 2029-08-24 | DP | |
9173857 | 2026-05-12 | U-2025 | |
Amphetamine, Adzenys Xr-Odt, Neos Theraps | |||
8840924 | 2026-04-09 | DP |
Code | Description |
---|---|
S0160 | Dextroamphetamine sulfate, 5 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 1 | — | — | — | — | 1 |
Drug common name | Amphetamine |
INN | amfetamine |
Description | 1-phenylpropan-2-amine is a primary amine that is isopropylamine in which a hydrogen attached to one of the methyl groups has been replaced by a phenyl group. |
Classification | Small molecule |
Drug class | CNS stimulant, anorectic |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CC(N)Cc1ccccc1 |
PDB | — |
CAS-ID | 300-62-9 |
RxCUI | — |
ChEMBL ID | CHEMBL405 |
ChEBI ID | 2679 |
PubChem CID | 3007 |
DrugBank | DB00182 |
UNII ID | CK833KGX7E (ChemIDplus, GSRS) |